Open Access
ARTICLE
Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma
1 Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China
2 Key Laboratory of System Medicine and Precision Diagnosis and Treatment of Taizhou, Taizhou, China
3 Department of Clinical Laboratory, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
4 School of Basic Medical Sciences Forensic Medicine, Hangzhou Medical College, Hangzhou, China
* Corresponding Authors: LINGZHI ZHANG. Email: ; JIAXI CHEN. Email:
# The aforementioned authors made an equal contribution to this study